Baxter (NYSE:BAX) said today that it plans to acquire non-invasive hemodynamic monitoring technologies provider Cheetah Medical for a price that could exceed $200 million. Deerfield, Ill.-based Baxter said will pay $190 million for Cheetah Medical upfront, with the potential for an additional $40 million based on clinical and commercial milestones. The acquisition will provide Baxter with […]
Cheetah Medical said last week that it raised $7 million in an equity round. The Newton, Mass.-based company makes noninvasive hemodynamic monitoring devices using an algorithm designed to allow physicians to examine a patient’s full hemodynamic profile. In a regulatory filing, Cheetah Medical said 16 unnamed investors participated in the round, with the first sale coming April […]
Cheetah Medical said today it raised $11.8 million in an expanded Series C funding round as it looks to grow its US footprint. Financing was provided by existing investors including MVM Life Science Partners, Springfield Investment Management, Fletcher Spaght Ventures, HighCape Partners and Robert Basch Venture Capital, the Newton, Mass.-based company said. Cheetah Medical provides noninvasive […]
Cheetah Medical said today it inked a supplier contract with non-for-profit healthcare system Allina Health. Through the contract, Minnesota and western Wisconsin based Allina Health will gain access to Cheetah Medical’s hemodynamic monitoring solutions to help guide volume management decisions in septic patients, Cheetah Medical said. “Intravenous fluid requirements vary significantly between patients based on underlying […]
Cheetah Medical is joining the Centers for Medicare and Medicaid Services in focusing on improving the treatment of sepsis in hospitals across the U.S. The Centers for Medicare and Medicaid Services released new federal reporting requirements for treating hospitalized sepsis patients on October 1. The new rules aim to monitor how sepsis is managed within […]
Cheetah Medical said it raised an initial $5 million investment from HighCape Partners for its non-invasive hemodynamic monitoring system.
Newton, Mass.-based Cheetah said the round is an extension of a prior raise that brought in $9 million.
Cheetah Medical said it added another $9 million to its coffers in a funding round led by Fletcher Spaght Ventures.
The Newton, Mass.-based medical device company, which makes a non-invasive hemodynamic monitoring system, said Springfield Investment Management, MVM Life Science Partners, Robert Bosch Venture Capital and Ascension Health Ventures also participated in the round.
Cheetah Medical shook up the C-suite this week, added a new CEO and a new medical chief – plus $14.5 million to the fluid management device maker’s coffers.